Congress will consider authorizing Medicare to negotiate lower drug prices. As discussed in this article.
In response, the drug industry argues that reducing their profits will reduce the number of new drugs they can develop.
I wonder if compromises like these have been considered?:
Can we continue to allow the market to determine most medicare drug prices, but also authorize Medicare to negotiate for those drugs that resist market forces such as those still under patents and for which there is no comparable competing drug?
Can we reduce the amount of regulation and cost of developing drugs?
Can we begin to consider drug evaluations that are conducted outside of the US?
Can we expedite the authorization of drug that were successfully developed and used overseas?
Can technology be used for “Virtual” evaluations?
Can we be more flexible on experimenting with drug for terminal cases?
Can we reconsider using prisoners or even illegal immigrants for testing drugs as part of their restitution to society?
Can we reduce the legal liabilities for drug that have unintended negative consequences if it can be established that the evaluation process was honorable?
Is there a way to lower drug prices without thwarting progress in the drug industry?
Born 1950, Married, Living in Austin Texas, Semi
Retired Small Business owner and investor. My political interest
evolved out of his business experience that the best decisions come out of an objective gathering of information and a pragmatic consideration of costs and benefits. I am interested in promoting Centrist candidates and Policies. My posts are mostly about people and policies that I believe are part of the solution rather the problem.